In an article posted on July 1, The Generics and Biosimilars Initiative (GaBI) presents an interesting Venn diagram of the partnerships among the players vying for the prospective biosimilars market:

Click here for diagram

The diagram clearly shows how the lines between innovator companies and generic companies is breaking down in the rush to develop biosimilars to the blockbuster biologics which are coming off patent in the next few years.